Medtronic Hugo Surgical Robot Receives FDA Clearance for General Surgery Procedures
Medtronic's Hugo robotic-assisted surgery system has received U.S. Food and Drug Administration (FDA) clearance for general surgery procedures, including upper and lower abdominal operations. This clearance expands the system's use beyond urology, enabling it to perform approximately 3.5 million surgeries annually in the U.S. The modular, cart-based system offers flexibility in port placement and reach for multi-quadrant procedures. Medtronic also noted its ongoing investment in AI technologies to enhance surgical planning, intraoperative guidance, and postoperative recovery.
Why it matters
The FDA clearance expands the Hugo system's applicability to approximately 3.5 million general surgery procedures annually in the U.S.
Source: The Robot Report — read the original
Source published 21 Nov 2026, 00:55 UTC